BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Total Liabilities 2019–2025
BridgeBio Pharma, Inc. annual/quarterly total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- BridgeBio Pharma, Inc. total liabilities for the quarter ending December 31, 2025 were 3.01B, a 26.74% increase year-over-year.
- BridgeBio Pharma, Inc. total liabilities for 2025 were 3.01B, a 26.74% increase from 2024.
- BridgeBio Pharma, Inc. total liabilities for 2024 were 2.38B, a 25.84% increase from 2023.
- BridgeBio Pharma, Inc. total liabilities for 2023 were 1.89B, a 1.12% increase from 2022.
- BridgeBio Pharma, Inc. total liabilities for 2022 were 1.87B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BridgeBio Pharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3,013 |
| 2024 | $2,377 |
| 2023 | $1,889 |
| 2022 | $1,868 |
| 2021 | $1,878 |
| 2020 | $596 |
| 2019 | $156 |
| BridgeBio Pharma, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $3,013 |
| 2024-12-31 | $2,377 |
| 2023-12-31 | $1,889 |
| 2022-12-31 | $1,868 |
| 2021-12-31 | $1,878 |
| 2020-12-31 | $596 |
| 2019-12-31 | $156 |
BridgeBio Pharma, Inc. Total Liabilities — FAQ
BridgeBio Pharma, Inc. (BBIO) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's total liabilities history?
The chart and table above show BridgeBio Pharma, Inc.'s total liabilities by year and by quarter, including the growth rate.